xerostomia market

Xerostomia is a condition characterized by dry mouth, which is a result of a reduced or absent flow of saliva. It is not a disease in itself, but a symptom of many such as diabetes, stroke, yeast infection (thrush) in your mouth or Alzheimer's disease, or due to autoimmune diseases, such as Sjogren's syndrome or HIV/AIDS.

DelveInsight's newsletter on Xerostomia presents the current trends of the Xerostomia market, epidemiology and treatment landscape. Learn more about the Xerostomia domain, and read about the recent happenings, key pharmaceutical companies in the Xerostomia market, key collaborations and agreements ongoing, and treatment breakthroughs in the Xerostomia therapy market.

Receive the latest news on ongoing R&D, clinical trials, and a lot more about the disease, underlying causes, therapeutic options, and unmet needs in the Xerostomia market directly in the email box by submitting the form towards your right. 

Xerostomia, commonly known as dry mouth, is a condition characterized by a decreased or absent flow of saliva in the mouth. While it is not a disease itself, it can be a symptom of various underlying conditions or a side effect of certain medications and treatments. Xerostomia affects quality of life significantly, interfering with taste, chewing, swallowing, and speaking, and often leads to complications such as dental decay, oral infections, and halitosis.

Subscribe to DelveInsight's mailing list and keep yourself abreast of the latest happenings in the pharmaceutical and healthcare industry.

Stay in the loop.